Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Patni Rajiv
Quince Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Patni Rajiv
Quince Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(7.5%),Tang Capital Management, LLC(7.5%), etc.
Quince Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sofinnova Capital VIII (“SC VIII”)(5.1%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(5.1%), etc.
Quince Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BML Investment Partners, L.P.(0.0%),Braden M Leonard(0.0%)
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ryan Charles S.
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hannah Brendan
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thye Dirk
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thye Dirk
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lamond David
Quince Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Genextra S.p.A.(5.89%),Francesco Micheli(5.89%), etc.
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lamond David
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lamond David
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hannah Brendan
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Benatti Luca
Quince Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Benatti Luca
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Janhofer Guenter
Quince Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Janhofer Guenter
Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-President Ryan Charles S.
Quince Therapeutics | 3: Initial statement of beneficial ownership of securities-President Ryan Charles S.
No Data